You could say that about 99% if penny stocks. It's high

New Post Public Reply Private Reply Replies (2) Message Board
redspeed Tanis2476 #25906
548
You could say that about 99% if penny stocks. It's high risk, high rewards. The chances of what any CEO says in any of those stocks is likely not to come true. It's why every presentation done at every company has that disclaimer. I knew that going in. With any of these penny stocks, if there is a date something is going to happen I double it and assume chances are it won't. Keeps me from getting my hopes up too high.

What's Amarantus's batting average? I don't know. Maybe 50%. A lot of bunts and singles, but no home runs and or runs scored. I can think of many times the company said they were going to do something and they did. But there are many other times it didn't pan out. There is a difference between will and want.

Being in the bio business you know this and one of the reasons why you, unlike a few others, didn't make it their career to whine on a messageboard and smart enough to step away. What a waste of a life for them and they do it on holiday's too.

"Dad, the turkey is getting cold"
"Just a dam minute, can't you see I'm busy on my commodore 64. I'm trying to post another one of those mymy things and it's taking forever"
So sad, too bad.

Getting back to the worthless Elto. If that was the case, then Dr. Lowe really tricked the company bring it to them. If that were the case, the company really tricked the FDA when they said they WOULD apply for orphan designation for Elto and they DID receive it.


But people hear what they want to here and would have taken that as the company WILL get orphan designation. Chances were not likely, but they did.

Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
Feb 10, 2016
https://www.prnewswire.com/news-releases/amar...96831.html

The fact of the matter is it's not easy to get orphan designations and the company as multiple. It's not easy to get patents, but the company has a boat load. Has that sent the stock to $100, obviously not, but at least in the last year, they haven't been sitting on their thumbs wondering what to do.

As far as no studies being done on worthless Elto in the last 10 years all it a takes is a 2 second google search to fine them. Here's a one.

Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
2013 Feb 6.
https://www.ncbi.nlm.nih.gov/pubmed/23389842

One may say - well that was from 4 years ago. That fits the window of the last 10 years. It's the first one I pulled up. I could post others but I'm not here to prove the value to the assets to every one. Just myself..

The more recent studies I've read in the last few years are from Europe and not always in English. I rarely have time to search private research portals which I assume you have access to. There is more in there.

You're a smart level headed poster so don't take any of this as aimed at you. Wish most people can be somewhere in the middle between the CEO is a liar and this is going to the moon on the 10th.







Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 100

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 67

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 162

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 207

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
MacKenzie-Childs Grinds Into Spotlight with Oprah's Nod

Updated Category News Views 69

Oprah's Golden Touch: 30 Years Strong Every year, there are a few select spots that brands covet like a hawk on a rabbit hunt. Getting on Oprah’s 'Favorite Things' list is surely one of them. Just like that, the MacKenzie-Childs Electric Salt and Pepper Grinder Set has muscled its way into the 2026 selection. Spare me the bells and whistles; this is like hitting the...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 120

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
NVIDIA Faces Fraud Suit: Investors Called to Action

Updated Category News Views 65

NVIDIA and the Quest for Accountability Nothing screams chaos in the market louder than a securities fraud lawsuit hitting the headlines. Investors currently eyeballing NVIDIA Corporation (NASDAQ: NVDA) are in for a wild ride. Yep, you heard it right—NVIDIA is smack in the middle of a class action lawsuit. They're being accused of misleading the market about some shady...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 94

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 173

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
CSMI Boosts CT's Cybersecurity for Defense Sector

Updated Category News Views 90

Paving the Way for Cybersecurity Excellence Out in chilly Connecticut, CSMI made a mark. The State's Office of Manufacturing picked them to join the advisory council for the Defense CyberSecure Program (CT-DCP). It ain’t just a pat on the back; it's a big deal for the region's defense and aerospace manufacturing gang. Connecticut's got its eyes set on beefing up its...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the New Beach Bungalows at Margaritaville Resort

Updated Category News Views 98

Unveiling the Beach Bungalows at Margaritaville Resort Camp Margaritaville Resort Crystal Beach is thrilled to unveil its brand-new residential offering, the Beach Bungalows. This exciting development invites potential homeowners to experience life along the enchanting shores of Crystal Beach. Experience Coastal Living Like Never Before For those seeking a tranquil...

Continue Reading
Carrier Global Corporation Declares New Quarterly Dividend

Updated Category News Views 199

Carrier Global Corporation Announces Quarterly Cash Dividend Carrier Global Corporation (NYSE: CARR), a leading entity in intelligent climate and energy solutions, is excited to inform its stakeholders about the declaration of a quarterly cash dividend. This dividend amounts to $0.225 for each share of the common stock held by shareholders. Dividend Payment and Record...

Continue Reading
Investors Alert: Class Action Filed Against Synopsys, Inc.

Updated Category News Views 127

Understanding the Class Action Lawsuit Against Synopsys, Inc. Recently, a class action lawsuit has been initiated against Synopsys, Inc. (NASDAQ: SNPS), centered around claims of securities fraud. This move, announced by Bernstein Liebhard LLP, has raised significant attention among shareholders who purchased or acquired securities of the Company. Who Should Be Concerned?...

Continue Reading
Modern Pediatrics Introduces Affordable Care with Home Visits

Updated Category News Views 319

Modern Pediatrics Launches Affordable Pediatric Care in Dallas Modern Pediatrics, a concierge pediatrics group based in Austin, is excited to bring their innovative services to the Dallas area. They are now offering in-home pediatric visits and 24/7 virtual care, a service that is truly a game-changer for families seeking accessible healthcare. Historically, home-based...

Continue Reading
Texas Pacific Land Corp Reports Insider Stock Purchases

Updated Category News Views 95

Executives at Texas Pacific Land Corp Make Noteworthy Stock Purchases Recently, executives at Texas Pacific Land Corp (NYSE: TPL), a key player in the oil royalty trading sector, made significant stock purchases. These transactions, revealed through recent SEC filings, were conducted under a prearranged trading plan, which allows insiders to buy shares without raising...

Continue Reading